Alnylam Pharmaceuticals (ALNY) EBITDA Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,003.00 |
| Dec 31, 2025 | 7,251.00 |
| Sep 30, 2025 | 17,493.00 |
| Jun 30, 2025 | 11,765.00 |
| Mar 31, 2025 | 4,412.00 |
| Dec 31, 2024 | 8,384.00 |
| Sep 30, 2024 | 8,770.00 |
| Jun 30, 2024 | 8,194.00 |
| Mar 31, 2024 | 9,484.00 |
| Dec 31, 2023 | 12,351.00 |
| Sep 30, 2023 | 22,474.00 |
| Jun 30, 2023 | 8,755.00 |
| Mar 31, 2023 | 12,590.00 |
| Dec 31, 2022 | 32,610.00 |
| Sep 30, 2022 | 14,139.00 |
| Jun 30, 2022 | 37,228.00 |
| Mar 31, 2022 | 43,036.00 |
| Dec 31, 2021 | 90,484.00 |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 45,774.00 |
| Mar 31, 2021 | 53,785.00 |
| Dec 31, 2020 | 22,403.00 |
| Sep 30, 2020 | 51,340.00 |
| Jun 30, 2020 | 57,060.00 |
| Mar 31, 2020 | 38,922.00 |
| Dec 31, 2019 | 29,119.00 |
| Sep 30, 2019 | 46,301.00 |
| Jun 30, 2019 | 75,882.00 |
| Mar 31, 2019 | 103,882.00 |
| Dec 31, 2018 | 4,355.00 |
| Sep 30, 2018 | -1.02 Mn |
| Jun 30, 2018 | 67,026.00 |
| Mar 31, 2018 | -39,238.00 |
| Dec 31, 2017 | -42,760.00 |
| Sep 30, 2017 | -25,495.00 |
| Jun 30, 2017 | -9,817.00 |
| Mar 31, 2017 | 240,042.00 |
| Dec 31, 2016 | -31,249.00 |
| Sep 30, 2016 | -41,770.00 |
| Jun 30, 2016 | -113,132.00 |
| Mar 31, 2016 | -156,345.00 |
| Dec 31, 2015 | -49,902.00 |
| Sep 30, 2015 | -150,977.00 |
| Jun 30, 2015 | -115,150.00 |
| Mar 31, 2015 | -19,979.00 |
| Dec 31, 2014 | 12,074.00 |
| Sep 30, 2014 | -39,966.00 |
| Jun 30, 2014 | -57,777.00 |
| Mar 31, 2014 | -288,691.00 |
| Dec 31, 2013 | -33,159.00 |
| Sep 30, 2013 | -30,608.00 |
| Jun 30, 2013 | -7,178.00 |
| Mar 31, 2013 | 2,906.00 |
| Dec 31, 2012 | -51,529.00 |
| Sep 30, 2012 | -7,849.00 |
| Jun 30, 2012 | 2,607.00 |